Skip to content

Notes From the Rabbit Hole

100% independent top-down macro market analysis and strategy

  • NFTRH Premium
    • NFTRH Report Archive [pw]
      • Previous Reports [pw]
    • NFTRH Interim Updates [pw]
    • Trade Log & Notes [pw]
    • Charts/Indicators [pw]
    • Subscribe: Info & Options
    • What NFTRH Is, Is Not
    • Why the Macro?
    • Fundamental vs. Technical
    • FAQ
    • Welcome to NFTRH
  • About
    • Our Tools
      • Macro Indicator: Gold-Silver Ratio (GSR)
      • Macro Indicator: T-Bond Continuum
      • Macro Indicator: Bond Yield Spreads, etc.
      • Sentiment/Psychology
      • Technical Analysis
    • Copyright
    • Early Articles
      • FrankenMarket Lives
      • Deflation: A Manufacturer’s View
    • Terms of Service & Privacy
    • Graphic/Icon sources
  • NFTRH Testimonials
    • Testimonials 2008-2014
  • Subscribe: Info & Options
  • Links
  • Contact
  • Free eLetter

Tag: pharmaceuticals

Stock Market, US

Time for Pharma to Out-Perform?

The Pharmaceutical ETF strikes an interesting pattern Man stares at the daily chart of PPH and gets geeked out on the pattern that has formed within a gentle uptrend. As long as it holds the SMA 50 man thinks it is prospective. Man also likes the positive RSI and MACD. Finally, man is also aware of the market’s various and ongoing rotations which, very lately, … Continue reading Time for Pharma to Out-Perform?

GaryApril 21, 2021April 21, 2021

“Best of breed” NFTRH

“Gary, Before NFTRH I used to feel a bit like Agent Starling in Buffalo Bill’s basement after the lights went out. Thanks for turning on the lights.” -John M

TRUMPETING: “I don’t often track gold & silver any longer but I do remember that at the end of October 2008 you and Bob Hoye were the only two advisors who were bullish. That was ideal, a couple of voices crying in the wilderness. I don’t know why you don’t trumpet that more.” –MM 11.10.14

Securely subscribe by credit card (Square)

NFTRH Monthly: $38

NFTRH Yearly: $390

By PayPal (monthly)

By PayPal (yearly)

My Tweets

Subscribe via Email

Enter your email address to receive all posts by email.

Join 822 other subscribers

Connect>>>

  • Facebook
  • Twitter
  • LinkedIn
Contributor to...
McVerry Report

Categories

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
 

Loading Comments...